Product Information
NISOLDIPINE ER 8.5 MG TABLET is a generic product labeled by Prasco Laboratories, priced at $3.5599 per EA under NDC 66993047202. Its NADAC has been published 471 times since Nov 28, 2013.
FDA first approved this application on Feb 2, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8.5 mg/1
Manufacturer
Prasco LaboratoriesNDC
66993047202
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NISOLDIPINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020356FDA Approved
2/2/1995
TE Code
AB
On Market Since
2/27/2012
Pharmacological Classes
Price Statistics
The NADAC for NISOLDIPINE ER 8.5 MG TABLET has been published 471 times since Nov 28, 2013, and over the history we have for it it has risen 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5599 per EA |
|---|---|
| All-time high | $4.3777 (Aug 15, 2018) |
| All-time low | $2.7972 (Nov 20, 2024) |
| 52-week high | $3.7211 |
| 52-week low | $3.4208 |
| Median price | $3.6310 |
| Average price | $3.6313 |
| Largest weekly change | +21.0% (Dec 18, 2013) |
| Weeks tracked | 471 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Nisoldipine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nisoldipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NISOLDIPINE ER 8.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NISOLDIPINE ER 8.5 MG TABLET, manufactured by Prasco Laboratories, is $3.5599 per EA (NDC 66993047202), effective Sep 30, 2026.
How has the price of NISOLDIPINE ER 8.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for NISOLDIPINE ER 8.5 MG TABLET has risen 5.7%. It has been tracked across 471 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NISOLDIPINE ER 8.5 MG TABLET?
Since Nov 28, 2013, the NADAC for NISOLDIPINE ER 8.5 MG TABLET has ranged from a low of $2.7972 (Nov 20, 2024) to a high of $4.3777 (Aug 15, 2018), with a median of $3.6310 per EA.
Are there cheaper alternatives to NISOLDIPINE ER 8.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NISOLDIPINE ER 8.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NISOLDIPINE ER 8.5 MG TABLET?
NISOLDIPINE ER 8.5 MG TABLET (NDC 66993047202) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.